open access

Vol 4, No 2 (2007)
Review paper
Published online: 2007-05-22
Get Citation

Pseudo-resistance to drug therapy

Joanna Meder, Magdalena Tyszkowska
Psychiatria 2007;4(2):53-59.

open access

Vol 4, No 2 (2007)
Prace poglądowe - nadesłane
Published online: 2007-05-22

Abstract


As many studies have proved, about 20-30% schizophrenic patients do not response on proper pharmacological treatment. This problem, called pharmacoresistance, is not always the result of a lack of drug effectiveness. It is often caused by irregular treatment, dose decreasing or drug withdrawal by the patient.
This paper describes a lack of patient compliance and its causes as well as attempts to break down the barriers. Some European researches findings on compliance in schizophrenia treatment (eg ADHES) are presented. The problem is equally common among patients in all European countries.
Clinical observations show benefits of long-acting drugs in out-patient setting as a high efficient treatment.

Abstract


As many studies have proved, about 20-30% schizophrenic patients do not response on proper pharmacological treatment. This problem, called pharmacoresistance, is not always the result of a lack of drug effectiveness. It is often caused by irregular treatment, dose decreasing or drug withdrawal by the patient.
This paper describes a lack of patient compliance and its causes as well as attempts to break down the barriers. Some European researches findings on compliance in schizophrenia treatment (eg ADHES) are presented. The problem is equally common among patients in all European countries.
Clinical observations show benefits of long-acting drugs in out-patient setting as a high efficient treatment.
Get Citation

Keywords

schizophrenia; treatment efficacy; patient compliance; long-acting drugs

About this article
Title

Pseudo-resistance to drug therapy

Journal

Psychiatria (Psychiatry)

Issue

Vol 4, No 2 (2007)

Article type

Review paper

Pages

53-59

Published online

2007-05-22

Bibliographic record

Psychiatria 2007;4(2):53-59.

Keywords

schizophrenia
treatment efficacy
patient compliance
long-acting drugs

Authors

Joanna Meder
Magdalena Tyszkowska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl